Pf. Piguet et al., Delayed mortality and attenuated thrombocytopenia associated with severe malaria in urokinase- and urokinase receptor-deficient mice, INFEC IMMUN, 68(7), 2000, pp. 3822-3829
We explored the role of urokinase and tissue-type plasminogen activators (u
PA and tPA), as well as the uPA receptor (uPAR; CD87 in mouse severe malari
a (SM), using genetically deficient (-/-) mice. The mortality resulting fro
m Plasmodium berghei ANKA infection was delayed in uPA(-/-) and uPAR(-/-) m
ice but was similar to that of the wild type (+/+) in tPA(-/-) mice. Parasi
temia levels were similar in uPA-/-, uPAR(-/-), and +/+ mice, Production of
tumor necrosis factor, as judged from the plasma level and the mRNA levels
in brain and lung, was markedly increased by infection in both +/+ and uPA
R(-/-) mice. Breakdown of the blood brain barrier, as evidenced by the leak
age of Evans Blue, was similar in +/+ and uPAR(-/-) mice. SM was associated
with a profound thrombocytopenia, which was attenuated in uPA(-/-) and uPA
R(-/-) mice. Administration of aprotinin, a plasmin antagonist, also delaye
d mortality and attenuated thrombocytopenia. Platelet trapping in cerebral
venules or alveolar capillaries was evident in +/+ mice but absent in uPAR(
-/-) mice. In contrast, macrophage sequestration in cerebral venules or alv
eolar capillaries was evident in both +/+ and uPAR(-/-) mice. Polymorphonuc
lear leukocyte sequestration in alveolar capillaries was similar in +/+ and
uPAR(-/-) mice. These results demonstrate that the uPAR deficiency attenua
tes the severity of SM, probably by its important role in platelet kinetics
and trapping, These results therefore suggest that platelet sequestration
contributes to the pathogenesis of SM.